menu
    • menu

    Company profile for Imaging Biometrics

    NEW Drugs in Dev: 1
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Imaging Biometrics, LLC (IB) develops ready-to-use software applications for the healthcare industry. The strength of IB is its extensive software development experience integrated with its client-centric approach. Through close collaborations with top research minds in the medical imaging field, proprietary and sophisticated advancements are translated into easy and intuitive analytical software solutions for researchers and ...
    Imaging Biometrics, LLC (IB) develops ready-to-use software applications for the healthcare industry. The strength of IB is its extensive software development experience integrated with its client-centric approach. Through close collaborations with top research minds in the medical imaging field, proprietary and sophisticated advancements are translated into easy and intuitive analytical software solutions for researchers and clinicians.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Imaging BiometricsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    13416 Watertown Plank Road, Suite 260 Elm Grove, WI 53122
    Telephone
    Telephone
    +1 2624398252
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.imagingbiometrics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/imaging-biometrics-llc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Expanded Access to Gallium Maltolate (GaM)

    Details:

    Gallium Maltolate is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Glioblastoma.


    Lead Product(s): Gallium Maltolate

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Miscellaneous

    Sponsor: xCures

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable May 08, 2024

    blank

    01

    Imaging Biometrics

    U.S.A
    arrow
    VMX
    Not Confirmed

    Imaging Biometrics

    U.S.A
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Gallium Maltolate

    Therapeutic Area : Oncology

    Highest Development Status : Undisclosed

    Partner/Sponsor/Collaborator : xCures

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Expanded Access to Gallium Maltolate (GaM)

    Details : Gallium Maltolate is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Glioblastoma.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    May 08, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    IQ-AI Announces Orphan Drug Designation for GaM in Pediatric GBM

    Details:

    Gallium maltolate is a orally administered drug is investigated for the treatment of pediatric glioblastoma multiforme patients and received Orphan Drug Designation from FDA.


    Lead Product(s): Gallium Maltolate

    Therapeutic Area: Oncology Brand Name: GaM

    Study Phase: PreclinicalProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable July 13, 2023

    blank

    02

    Imaging Biometrics

    U.S.A
    arrow
    VMX
    Not Confirmed

    Imaging Biometrics

    U.S.A
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Gallium Maltolate

    Therapeutic Area : Oncology

    Highest Development Status : Preclinical

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    IQ-AI Announces Orphan Drug Designation for GaM in Pediatric GBM

    Details : Gallium maltolate is a orally administered drug is investigated for the treatment of pediatric glioblastoma multiforme patients and received Orphan Drug Designation from FDA.

    Product Name : GaM

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    July 13, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search